Renal Cell Carcinoma [clinicaltrials_resource:fd3bec4ec41be99313607e47079bc05d]
A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer [clinicaltrials:NCT00001683]clinicaltrials:NCT00001703Active Immunotherapy Of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNA [clinicaltrials:NCT00006431]Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance [clinicaltrials:NCT00026663]clinicaltrials:NCT00030992Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer [clinicaltrials:NCT00033904]Study of CP-461 in Patients With Advanced Renal Cell Cancer [clinicaltrials:NCT00036036]ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer [clinicaltrials:NCT00056537]A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Carcinoma [clinicaltrials:NCT00081614]Trial to Compare the Routes of Administration of an Investigational, Personalized, Therapeutic Cancer Vaccine Oncophage (HSPPC-96) in Patients With Metastatic Renal Cell Carcinoma [clinicaltrials:NCT00082459]RNA-Loaded Dendritic Cell Cancer Vaccine [clinicaltrials:NCT00087984]Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC) [clinicaltrials:NCT00100685]clinicaltrials:NCT00113217Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney Cancer [clinicaltrials:NCT00126178]Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell Carcinoma [clinicaltrials:NCT00176280]Treatment of Patients With Advanced Renal Cancer With a Radio-labeled Antibody, Yttrium-90 Conjugated Chimeric G250 [clinicaltrials:NCT00199875]clinicaltrials:NCT00258687clinicaltrials:NCT00272649Study of XL999 in Patients With Metastatic Renal Cell Carcinoma [clinicaltrials:NCT00277316]clinicaltrials:NCT00323076clinicaltrials:NCT00330564Case-Control Study of Renal Cell Cancer Among Caucasions and African Americans in the United States [clinicaltrials:NCT00340457]clinicaltrials:NCT00353301A Rollover Study for Patients Who Received CP-675,206 in Other Protocols, to Allow the Patients Access to CP-675,206 Until This Agent Becomes Commercially Available or Development is Discontinued. [clinicaltrials:NCT00378482]clinicaltrials:NCT00384969A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell Carcinoma [clinicaltrials:NCT00417677]ABR-217620/Naptumomab Estafenatox With Interferon-alpha (IFN-alpha) Compared to IFN-alpha Alone in Patients With Advanced Renal Cell Carcinoma [clinicaltrials:NCT00420888]clinicaltrials:NCT00422344clinicaltrials:NCT00423332A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal Cancer [clinicaltrials:NCT00448721]clinicaltrials:NCT00460798clinicaltrials:NCT00474786Efficacy and Safety of Sorafenib in Advanced Renal Cell Carcinoma (RCC) [clinicaltrials:NCT00478114]clinicaltrials:NCT00480389clinicaltrials:NCT00480935A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma [clinicaltrials:NCT00485563]clinicaltrials:NCT00490698clinicaltrials:NCT00491075clinicaltrials:NCT00491738Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma [clinicaltrials:NCT00496587]
condition [clinicaltrials_vocabulary:condition]
Renal Cell Carcinoma [clinicaltrials_resource:fd3bec4ec41be99313607e47079bc05d]
Bio2RDF identifier
fd3bec4ec41be99313607e47079bc05d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:fd3bec4ec41be99313607e47079bc05d
identifier
clinicaltrials_resource:fd3bec4ec41be99313607e47079bc05d
title
Renal Cell Carcinoma
@en
label
Renal Cell Carcinoma [clinicaltrials_resource:fd3bec4ec41be99313607e47079bc05d]
@en